# Westrock Coffee Co: financial statements, quarterly

WEST · Nasdaq · CIK 1806347 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/west.md) · [Financials](/companies/west/financials.md) · [Filings](/companies/west/filings.md) · [Insiders](/companies/west/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/west/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [220](/filings/0001558370-24-014906.md) | [215 d](/filings/0001104659-26-025932.md) | [193](/filings/0001558370-25-007010.md) | [208](/filings/0001558370-25-010772.md) | [221](/filings/0001104659-25-107840.md) | [229 d](/filings/0001104659-26-025932.md) | [214](/filings/0001104659-26-057284.md) | [281](/filings/0001104659-26-092129.md) | [355](/filings/0001104659-25-107840.md) | [339 d](/filings/0001104659-26-025932.md) | [309](/filings/0001104659-26-057284.md) | [306](/filings/0001104659-26-092129.md) |
| Cost of revenue | $m | [185](/filings/0001558370-24-014906.md) | [180 d](/filings/0001104659-26-025932.md) | [155](/filings/0001558370-25-007010.md) | [167](/filings/0001558370-25-010772.md) | [184](/filings/0001104659-25-107840.md) | [191 d](/filings/0001104659-26-025932.md) | [185](/filings/0001104659-26-057284.md) | [239](/filings/0001104659-26-092129.md) | [313](/filings/0001104659-25-107840.md) | [301 d](/filings/0001104659-26-025932.md) | [263](/filings/0001104659-26-057284.md) | [268](/filings/0001104659-26-092129.md) |
| Gross profit | $m | [35.1](/filings/0001558370-24-014906.md) | [34.8 d](/filings/0001104659-26-025932.md) | [37.3](/filings/0001558370-25-007010.md) | [41.4](/filings/0001558370-25-010772.md) | [37.1](/filings/0001104659-25-107840.md) | [38.0 d](/filings/0001104659-26-025932.md) | [29.1](/filings/0001104659-26-057284.md) | [41.4](/filings/0001104659-26-092129.md) | [41.4](/filings/0001104659-25-107840.md) | [38.9 d](/filings/0001104659-26-025932.md) | [45.8](/filings/0001104659-26-057284.md) | [37.7](/filings/0001104659-26-092129.md) |
| Selling, general and administrative | $m | [37.1](/filings/0001558370-24-014906.md) | [39.3 d](/filings/0001104659-26-025932.md) | [44.4](/filings/0001558370-25-007010.md) | [51.6](/filings/0001558370-25-010772.md) | [46.1](/filings/0001104659-25-107840.md) | [43.0 d](/filings/0001104659-26-025932.md) | [40.3](/filings/0001104659-26-057284.md) | [53.9](/filings/0001104659-26-092129.md) | [47.0](/filings/0001104659-25-107840.md) | [44.2 d](/filings/0001104659-26-025932.md) | [37.8](/filings/0001104659-26-057284.md) | [36.0](/filings/0001104659-26-092129.md) |
| Operating income | $m | [(5.4)](/filings/0001558370-24-014906.md) | [(6.4) d](/filings/0001104659-26-025932.md) | [(10.1)](/filings/0001558370-25-007010.md) | [(16.4)](/filings/0001558370-25-010772.md) | [(12.7)](/filings/0001104659-25-107840.md) | [(9.8) d](/filings/0001104659-26-025932.md) | [(13.1)](/filings/0001104659-26-057284.md) | [(15.0)](/filings/0001104659-26-092129.md) | [(8.6)](/filings/0001104659-25-107840.md) | [(8.7) d](/filings/0001104659-26-025932.md) | [3.2](/filings/0001104659-26-057284.md) | [(1.4)](/filings/0001104659-26-092129.md) |
| Interest expense | $m | [7.8](/filings/0001558370-23-018624.md) | [7.9 d](/filings/0001558370-24-003417.md) | [7.6](/filings/0001558370-24-007645.md) | [7.5](/filings/0001558370-25-010772.md) | [6.9](/filings/0001104659-25-107840.md) | [11.9 d](/filings/0001104659-26-025932.md) | [12.6](/filings/0001104659-26-057284.md) | [13.1](/filings/0001104659-26-092129.md) | [14.0](/filings/0001104659-25-107840.md) | [16.0 d](/filings/0001104659-26-025932.md) | [13.5](/filings/0001104659-26-057284.md) | [13.0](/filings/0001104659-26-092129.md) |
| Income tax | $m | [(5.2)](/filings/0001558370-24-014906.md) | [(3.0) d](/filings/0001104659-26-025932.md) | [5.8](/filings/0001558370-25-007010.md) | [(4.6)](/filings/0001558370-25-010772.md) | [0.1](/filings/0001104659-25-107840.md) | [2.5 d](/filings/0001104659-26-025932.md) | [1.8](/filings/0001104659-26-057284.md) | [(0.4)](/filings/0001104659-26-092129.md) | [(0.1)](/filings/0001104659-25-107840.md) | [(3.1) d](/filings/0001104659-26-025932.md) | [2.0](/filings/0001104659-26-057284.md) | [(0.4)](/filings/0001104659-26-092129.md) |
| Net income | $m | [16.6](/filings/0001558370-24-014906.md) | [(20.1) d](/filings/0001104659-26-025932.md) | [(23.7)](/filings/0001558370-25-007010.md) | [(17.8)](/filings/0001558370-25-010772.md) | [(14.3)](/filings/0001104659-25-107840.md) | [(24.6) d](/filings/0001104659-26-025932.md) | [(27.2)](/filings/0001104659-26-057284.md) | [(21.6)](/filings/0001104659-26-092129.md) | [(19.1)](/filings/0001104659-25-107840.md) | [(22.6) d](/filings/0001104659-26-025932.md) | [(8.5)](/filings/0001104659-26-057284.md) | [(13.7)](/filings/0001104659-26-092129.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001558370-24-014906.md) | not reported | [(0.27)](/filings/0001558370-25-007010.md) | [(0.20)](/filings/0001558370-25-010772.md) | [(0.16)](/filings/0001104659-25-107840.md) | not reported | [(0.29)](/filings/0001104659-26-057284.md) | [(0.23)](/filings/0001104659-26-092129.md) | [(0.20)](/filings/0001104659-25-107840.md) | not reported | [(0.09)](/filings/0001104659-26-057284.md) | [(0.14)](/filings/0001104659-26-092129.md) |
| Basic EPS | $ per share | [0.15](/filings/0001558370-24-014906.md) | not reported | [(0.27)](/filings/0001558370-25-007010.md) | [(0.20)](/filings/0001558370-25-010772.md) | [(0.16)](/filings/0001104659-25-107840.md) | not reported | [(0.29)](/filings/0001104659-26-057284.md) | [(0.23)](/filings/0001104659-26-092129.md) | [(0.20)](/filings/0001104659-25-107840.md) | not reported | [(0.09)](/filings/0001104659-26-057284.md) | [(0.14)](/filings/0001104659-26-092129.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [44.4](/filings/0001558370-24-014906.md) | [37.2](/filings/0001558370-25-002804.md) | [12.6](/filings/0001558370-25-007010.md) | [24.3](/filings/0001558370-25-010772.md) | [22.4](/filings/0001104659-25-107840.md) | [26.2](/filings/0001104659-26-025932.md) | [35.9](/filings/0001104659-26-057284.md) | [44.0](/filings/0001104659-26-092129.md) | [34.0](/filings/0001104659-25-107840.md) | [49.9](/filings/0001104659-26-092129.md) | [28.1](/filings/0001104659-26-057284.md) | [38.2](/filings/0001104659-26-092129.md) |
| Current assets | $m | [340](/filings/0001558370-23-018624.md) | [313](/filings/0001558370-25-002804.md) | [273](/filings/0001558370-24-007645.md) | [333](/filings/0001558370-24-011646.md) | [337](/filings/0001558370-24-014906.md) | [334](/filings/0001104659-26-025932.md) | [364](/filings/0001558370-25-007010.md) | [377](/filings/0001558370-25-010772.md) | [394](/filings/0001104659-25-107840.md) | [396](/filings/0001104659-26-092129.md) | [344](/filings/0001104659-26-057284.md) | [330](/filings/0001104659-26-092129.md) |
| Total assets | $m | [891](/filings/0001558370-24-014906.md) | [972](/filings/0001104659-26-025932.md) | [983](/filings/0001558370-25-007010.md) | [1,056](/filings/0001558370-25-010772.md) | [1,077](/filings/0001104659-25-107840.md) | [1,102](/filings/0001104659-26-025932.md) | [1,139](/filings/0001104659-26-057284.md) | [1,157](/filings/0001104659-26-092129.md) | [1,178](/filings/0001104659-25-107840.md) | [1,176](/filings/0001104659-26-092129.md) | [1,116](/filings/0001104659-26-057284.md) | [1,086](/filings/0001104659-26-092129.md) |
| Current liabilities | $m | [222](/filings/0001558370-23-018624.md) | [240](/filings/0001558370-25-002804.md) | [220](/filings/0001558370-24-007645.md) | [254](/filings/0001558370-24-011646.md) | [242](/filings/0001558370-24-014906.md) | [278](/filings/0001104659-26-025932.md) | [309](/filings/0001558370-25-007010.md) | [361](/filings/0001558370-25-010772.md) | [385](/filings/0001104659-25-107840.md) | [414](/filings/0001104659-26-092129.md) | [354](/filings/0001104659-26-057284.md) | [342](/filings/0001104659-26-092129.md) |
| Total liabilities | $m | [491](/filings/0001558370-23-018624.md) | [584](/filings/0001558370-25-002804.md) | [617](/filings/0001558370-24-007645.md) | [701](/filings/0001558370-24-011646.md) | [693](/filings/0001558370-24-014906.md) | [730](/filings/0001104659-26-025932.md) | [794](/filings/0001558370-25-007010.md) | [866](/filings/0001558370-25-010772.md) | [893](/filings/0001104659-25-107840.md) | [904](/filings/0001104659-26-092129.md) | [863](/filings/0001104659-26-057284.md) | [844](/filings/0001104659-26-092129.md) |
| Long-term debt | $m | [206](/filings/0001558370-23-018624.md) | [223](/filings/0001558370-25-002804.md) | [224](/filings/0001558370-24-007645.md) | [280](/filings/0001558370-24-011646.md) | [326](/filings/0001558370-24-014906.md) | [326](/filings/0001104659-26-025932.md) | [357](/filings/0001558370-25-007010.md) | [378](/filings/0001558370-25-010772.md) | [384](/filings/0001104659-25-107840.md) | [357](/filings/0001104659-26-092129.md) | [375](/filings/0001104659-26-057284.md) | [365](/filings/0001104659-26-092129.md) |
| Current portion of debt | $m | [9.3](/filings/0001558370-23-018624.md) | [9.8](/filings/0001558370-25-002804.md) | [12.1](/filings/0001558370-24-007645.md) | [12.1](/filings/0001558370-24-011646.md) | [12.1](/filings/0001558370-24-014906.md) | [14.1](/filings/0001104659-26-025932.md) | [15.1](/filings/0001558370-25-007010.md) | [16.5](/filings/0001558370-25-010772.md) | [17.9](/filings/0001104659-25-107840.md) | [19.3](/filings/0001104659-26-092129.md) | [20.7](/filings/0001104659-26-057284.md) | [22.6](/filings/0001104659-26-092129.md) |
| Short-term borrowings | $m | [53.0](/filings/0001558370-23-018624.md) | [43.7](/filings/0001558370-25-002804.md) | [34.4](/filings/0001558370-24-007645.md) | [54.6](/filings/0001558370-24-011646.md) | [58.0](/filings/0001558370-24-014906.md) | [54.7](/filings/0001104659-26-025932.md) | [58.8](/filings/0001558370-25-007010.md) | [75.2](/filings/0001558370-25-010772.md) | [84.1](/filings/0001104659-25-107840.md) | [82.6](/filings/0001104659-26-092129.md) | [60.4](/filings/0001104659-26-057284.md) | [55.8](/filings/0001104659-26-092129.md) |
| Shareholders' equity | $m | [126](/filings/0001558370-23-018624.md) | [114](/filings/0001104659-25-107840.md) | [91.7](/filings/0001558370-25-010772.md) | [81.5](/filings/0001104659-25-107840.md) | [110](/filings/0001104659-25-107840.md) | [97.5](/filings/0001104659-26-092129.md) | [71.4](/filings/0001104659-26-092129.md) | [18.2](/filings/0001104659-26-092129.md) | [11.4](/filings/0001104659-25-107840.md) | [(1.9)](/filings/0001104659-26-092129.md) | [(20.2)](/filings/0001104659-26-092129.md) | [(31.3)](/filings/0001104659-26-092129.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(39.5) d](/filings/0001558370-24-014906.md) | [11.1 d](/filings/0001104659-26-025932.md) | [8.0](/filings/0001558370-25-007010.md) | [(23.7) d](/filings/0001558370-25-010772.md) | [(0.3) d](/filings/0001104659-25-107840.md) | [2.8 d](/filings/0001104659-26-025932.md) | [(22.1)](/filings/0001104659-26-057284.md) | [(7.0) d](/filings/0001104659-26-092129.md) | [(26.6) d](/filings/0001104659-25-107840.md) | [36.7 d](/filings/0001104659-26-025932.md) | [(11.8)](/filings/0001104659-26-057284.md) | [26.7 d](/filings/0001104659-26-092129.md) |
| Capital expenditure | $m | [65.8 d](/filings/0001558370-24-014906.md) | [43.1 d](/filings/0001104659-26-025932.md) | [68.9](/filings/0001558370-25-007010.md) | [36.2 d](/filings/0001558370-25-010772.md) | [36.3 d](/filings/0001104659-25-107840.md) | [18.2 d](/filings/0001104659-26-025932.md) | [41.3](/filings/0001104659-26-057284.md) | [20.5 d](/filings/0001104659-26-092129.md) | [18.1 d](/filings/0001104659-25-107840.md) | [8.9 d](/filings/0001104659-26-025932.md) | [7.1](/filings/0001104659-26-057284.md) | [6.5 d](/filings/0001104659-26-092129.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.8](/filings/0001558370-23-018624.md) | [76.7](/filings/0001558370-24-007645.md) | [75.7](/filings/0001558370-24-011646.md) | [107](/filings/0001558370-24-014906.md) | [88.1](/filings/0001558370-25-007010.md) | [88.3](/filings/0001558370-25-010772.md) | [88.5](/filings/0001104659-25-107840.md) | [94.3](/filings/0001104659-26-057284.md) | [94.7](/filings/0001104659-26-092129.md) | [95.6](/filings/0001104659-25-107840.md) | [97.0](/filings/0001104659-26-057284.md) | [97.6](/filings/0001104659-26-092129.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 97,627,387 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092129.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.